COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health Decision

Nursing home residents (NHR) have been targeted as a vaccination priority due to their higher risk of worse outcome after COVID-19 infection. The mRNA-based vaccine BTN2b2 was first approved in Europe for NHRs. The assessment of the specific vaccine immune response (both humoral and cellular) at lon...

Descripció completa

Dades bibliogràfiques

Autors principals:	David San Segundo, Alejandra Comins-Boo, Patricia Lamadrid-Perojo, Juan Irure-Ventura, José María Castillo-Otí, Reinhard Wallman, Jorge Calvo-Montes, José Manuel Méndez-Legaza, Carmela Baamonde-Calzada, Isabel Sánchez-Molina, Marina Lecue-Martínez, Silvia Ventisca-Pérez, Ana Batlle-López, Marcos López Hoyos
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-12-01
Col·lecció:	Vaccines
Matèries:	mRNA vaccine SARS-CoV-2 cellular-immune response nursing home residents public health
Accés en línia:	https://www.mdpi.com/2076-393X/9/12/1429
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!